Dr. Wood received her MSN in Cardiovascular Nursing from University of Alabama, Birmingham and her PhD in Physiological Nursing from the University of California, San Francisco. Before joining Emory, she was a faculty member for eight years at Duke University School of Nursing.

Areas of Expertise

Acute & Chronic Care
Biological Behavioral/omics
Cardiovascular Health
Symptom Science


Wood, K.A., Barnes, A.H., Paul, S., Hines, K.A., & Jackson K.P. (2018). Symptom challenges after atrial fibrillation ablation. Heart & Lung, 46(6), 425-431. PMID: 28923248. PMCID: PMC5811184. doi: 10.1016/j.hrtlng.2017.08.007

Barnason, S., White-Williams, C., Rossi, L.P., Centeno, M., Crabbe, D.L., Lee, K.S., McCabe, N., Nauser, J., Schulz, P., Stamp, K., Wood, K.; on behalf of the American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. (2017). Evidence for Therapeutic Patient Education Interventions to Promote Cardiovascular Patient Self-Management: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circ Cardiovasc Qual Outcomes, 10(6):e000025. PMID: 28630370. doi: 10.1161/HCQ.0000000000000025.

White, J., Withers, K.L., Lencioni, M., Carolan-Rees, G., Wilkes, A.R., Wood, K.A., Patrick, H., Cunningham, D. & Griffith, M. (2016). Cardiff cardiac ablation patient-reported outcome measure (C-CAP): validation of a new questionnaire set for patients undergoing catheter ablation for cardiac arrhythmias in the UK. Quality of Life Research, 26(6); 1571-1583. PMID: 26659900, doi: 10.1007/s11136-015-1194-1.

Lane, D.A. & Wood, K. (2015). A Patient’s Guide to Taking the Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) for Atrial Fibrillation. Circulation, 131(16), e412-e415. PMID: 25901074.

Withers, K.L., Wood, K.A., Carolan-Rees, G., Patrick, H., Lencioni, M. & Griffith, M. (2015). Living on a Knife Edge - the daily struggle of coping with Symptomatic Cardiac Arrhythmias. Health Quality of Life Outcomes, 13(7), 86-92. PMID: 26104746, doi: 10.1186/s12955-015-0282-9.

Furie, K.L., Goldstein, L.B., Albers, G.W., Khatri, P., Neyens, R., Turakhia, M.P., Turan, T.N. & Wood, K.W., American Heart Association Stroke Council; Council on Quality of Care and Outcomes Research; Council on Cardiovascular Nursing; Council on Clinical Cardiology; & Council on Peripheral Vascular Disease. (2012). Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: A science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 43(12), 3442-53. PMID: 22858728.

Wood, K.A., Stewart, A.L., Drew, B.J., Scheinman, M.M. & Froëlicher, E.S. (2010). Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia. Heart & Lung, 39(1), 12-20. PMID: 20109982, PMCID: 2817962.

Wood, K.A., Stewart, A.L., Drew, B.J., Scheinman, M.M. & Froëlicher, E.S. (2009). Development and initial psychometric evaluation of the Patient Perspective of Arrhythmia Questionnaire. Research in Nursing and Health, 32(5), 504-516. PMID: 19701927, PMCID: 2953868.

Wood, K.A., Wiener, C.L. & Kayser-Jones, J. (2007). Supraventricular tachycardia and the struggle to be believed. European Journal of Cardiovascular Nursing, 6(4), 293-302. PMID: 17409024, PMCID: 2267208.

Wood, K.A., Eisenberg, S., Kalman, J., Drew, B.J., Saxon, L.A., Lee, R.J., Lesh, M.D. & Scheinman, M.M. (1997). Risk of thromboembolism in chronic atrial flutter. American Journal of Cardiology, 79(8), 1043-1047. PMID: 9114761

Wood, K.A., Drew, B.J. & Scheinman, M.M. (1997). Frequency of disabling symptoms in supraventricular tachycardia. American Journal of Cardiology, 79(2), 145-149. PMID: 9193013.


Dr. Wood teaches a health outcomes doctoral seminar, an undergraduate statistics course, and a masters level evidence based practice course.